Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Harrison

Showing results (791-800 of 880) with videos related to

Pageof 88
Sort By:
The Journal of Dermatological Treatment|December 3, 2020
Disease response and patient-reported outcomes among initiators of ixekizumabMona Shahriari, Ryan W Harrison, Russel Burge, et al.
Nature Genetics|October 15, 1998
Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouseD Morgan, L Turnpenny, J Goodship, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
Respiratory Research|April 6, 2011
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment stepsEric D Bateman, Tim W Harrison, Santiago Quirce, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2017
Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary diseaseReham Shindi, Amna Almehairi, Ola H Negm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice SubstudyRenaud Louis, Tim W Harrison, Pascal Chanez, et al.
Gastro Hep Advances|August 12, 2024
Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in RemissionRaymond K Cross, Jenny S Sauk, Joe Zhuo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2020
Early-onset pancreatic cancer: an institutional series evaluating end-of-life careKunal C Kadakia, Sally J Trufan, Megan H Jagosky, et al.
Crohn'S & Colitis 360|February 13, 2023
Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas' Inflammatory Bowel Disease RegistryRaymond K Cross, April N Naegeli, Ryan W Harrison, et al.
Scientific Reports|June 13, 2020
Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in IndiaJames W Harrison, Divya Sri Priyanka Tallapragada, Alma Baptist, et al.
Pageof 88

Showing results (791-800 of 880) with videos related to

Sort By:
Pageof 88
The Journal of Dermatological Treatment|December 3, 2020
Disease response and patient-reported outcomes among initiators of ixekizumabMona Shahriari, Ryan W Harrison, Russel Burge, et al.
Nature Genetics|October 15, 1998
Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouseD Morgan, L Turnpenny, J Goodship, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
Respiratory Research|April 6, 2011
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment stepsEric D Bateman, Tim W Harrison, Santiago Quirce, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2017
Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary diseaseReham Shindi, Amna Almehairi, Ola H Negm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice SubstudyRenaud Louis, Tim W Harrison, Pascal Chanez, et al.
Gastro Hep Advances|August 12, 2024
Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in RemissionRaymond K Cross, Jenny S Sauk, Joe Zhuo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2020
Early-onset pancreatic cancer: an institutional series evaluating end-of-life careKunal C Kadakia, Sally J Trufan, Megan H Jagosky, et al.
Crohn'S & Colitis 360|February 13, 2023
Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas' Inflammatory Bowel Disease RegistryRaymond K Cross, April N Naegeli, Ryan W Harrison, et al.
Scientific Reports|June 13, 2020
Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in IndiaJames W Harrison, Divya Sri Priyanka Tallapragada, Alma Baptist, et al.
Pageof 88